XVII. Lipid metabolism of Pneumocystis: toward the definition of new molecular targets

FEMS Immunology and Medical Microbiology

Volumn 22, Issue 1-2, 1998, Pages 135-143

  Kaneshiro, Edna S ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

C 24 alkylated sterols; cis 9,10 Epoxy stearic acid; Lipid metabolism; Purified Pneumocystis carinii; Sterol 8 to 7 isomerase; Ubiquinone

Indexed keywords

STEARIC ACID DERIVATIVE; STEROL DERIVATIVE; UBIQUINONE; 9,10 EPOXYSTEARIC ACID; 9,10-EPOXYSTEARIC ACID; STEROL;

ARTICLE; LIPID METABOLISM; NONHUMAN; PNEUMOCYSTIS; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; METABOLISM; ULTRASTRUCTURE;

PNEUMOCYSTIS;

LIPID METABOLISM; PNEUMOCYSTIS; STEARIC ACIDS; STEROLS; UBIQUINONE;

EID: 0032148381     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(98)00071-6     Document Type: Article

References (31)

1. Rodriguez, R.J. and Parks, L.W. (1983) Structural and physiological features of sterols necessary to satisfy bulk membrane and sparking requirements in yeast auxotrophs. Arch. Biochem. Biophys. 22, 861-871.
2. Haughan, P.A. and Goad, L.J. (1991) Lipid biochemistry of trypanosomatids. In: Biochemical Protozoology (Coombs, G.H. and North, M.D., Eds.), pp. 312-328. Taylor and Francis, London.
3. Pesanti, E.L. (1987) Phospholipid profile of Pneumocystis carinii and its interaction with alveolar type II epithelial cells. Infect. Immun. 55, 736-774.
4. Kaneshiro, E.S., Cushion, M.T., Walzer, P.D. and Jayasimhulu, K. (1989) Analysis of Pneumocystis fatty acids. J. Protozool. 36, 85S-87S.
5. Paulsrud, J.R., Queener, S.F., Bartlett, M.S. and Smith, J.W. (1993) Total cellular fatty acid composition of cultured Pneumocystis carinii. J. Clin. Microbiol. 31, 1899-1902.
6. Furlong, S.T., Samia, J.A., Rogers, R.M. and Fishman, J.A. (1994) Phytosterols are present in Pneumocystis carinii. Antimicrob. Agents Chemother. 38, 2534-2540.
7. Paulsrud, J.R. and Queener, S.F. (1994) Metabolism of fatty acids and amino acids by cultured Pneumocystis carinii. J. Eukaryote. Microbiol. 41, 633-638.
8. 24(25) sterol methyltransferase block sterol synthesis and cell proliferation in Pneumocystis carinii. Antimicrob. Agents Chemother. 14, 1428-1432.
9. Zimmerman, P.E., Voelker, D.R., McCormack, F.X. and Martin, W.J. (1992) 120 kDa surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J. Clin. Invest. 89, 143-149.
10. Boylan, C.J., and Current, W.L. (1992) Improved model of Pneumocystis carinii pneumonia: induced laboratory infection in Pneumocystis-free animals. Infect. Immun. 60, 1589-1597.
11. Kaneshiro, E.S., Wyder, M.A., Zhou, L.H., Ellis, J.E., Voelker, D.R. and Langreth, S.G. (1993) Characterization of Pneumocystis carinii preparations developed for lipid analysis. J. Eukaryote. Microbiol. 40, 805-815.
12. Florin-Christensen, M., Florin-Christensen, J., Wu, Y.-P., Zhou, L.H., Gupta, A., Rudney, H. and Kaneshiro, E.S. (1993) Occurrence of specific sterols in Pneumocystis carinii. Biochem. Biophys. Res. Commun. 198, 236-242.
13. Kaneshiro, E.S., Ellis, J.E., Jayasimhulu, K. and Beach, D.H. (1994) Evidence for the presence of 'metabolic sterols' in Pneumocystis: identification and initial characterization of Pneumocystis carinii sterols. J. Eukaryote. Microbiol. 41, 78-85.
14. Guo, Z. and Kaneshiro, E.S. (1995) Phospholipid composition of Pneumocystis carinii and the effects of methylprednisolone immunosuppression on rat lung lipids. Infect. Immun. 63, 1286-1290.
15. 10 as the major ubiquinone homolog. J. Eukaryote. Microbiol. 43, 165-170.
16. Kaneshiro, E.S., Ellis, J.E., Guo, Z., Jayasimhulu, K., Maiorano, J.N. and Kallam, K.A. (1996) Characterizations of neutral lipid fatty acids and cis-9,10-epoxy octadecanoic acid in Pneumocystis carinii carinii. Infect. Immun. 64, 4105-4114.
17. Guo, Z., Beach, D.H. and Kaneshiro, E.S. (1996) Fatty acid composition of the major phospholipids of Pneumocystis carinii carinii: comparison with those of the lungs of normal and methylprednisolone-immunosuppressed rats. Infect. Immun. 64, 1407-1412.
18. Kaneshiro, E.S., Wu, Y.-P. and Cushion, M.T. (1991) Assays for testing Pneumocystis carinii viability. J. Protozool. 38, 85S-87S.
19. Kaneshiro, E.S., Wyder, M.A., Wu, Y.-P. and Cushion, M.T. (1993) Reliability of calcein methoxy methyl ester and ethidium homodimer or propidium iodide for viability assessment of microbes. J. Microbiol. Methods 17, 1-16.
20. Kaneshiro, E.S., Ellis, J.E., Zhou, L.H., Rudney, H., Gupta, A., Jayasimhulu, K., Setchell, K.D. and Beach, D.H. (1995) Isoprenoid metabolism in Pneumocystis carinii. J. Eukaryote. Microbiol. 41, 93S.
21. Florin-Christensen, M., Florin-Christensen, J. and Kaneshiro, E.S. (1995) Uptake and metabolism of L-serine by Pneumocystis carinii carinii. J. Eukaryote. Microbiol. 42, 669-675.
22. Nes, W.D., Hanners, P.K. and Parish, E.L. (1986) Inhibitors of fungal sterol C-24 alkylation: importance to developmental regulation. Biochem. Biophys. Res. Commun. 139, 410-415.
23. Beach, D.H., Chen, F., Cushion, M.T., Macomber, R.S., Krudy, G.A., Wyder, M.A. and Kaneshiro, E.S. (1997) Effects of steroidal allenic phosphonic acid derivatives on the parasitic protists Leishmania donovani, Leishmania mexicana mexicana and Pneumocystis carinii carinii. Antimicrob. Agents Chemother. 41, 162-168.
24. Sul, D. and Kaneshiro, E.S. (1997) Ubiquinone synthesis by Pneumocystis carinii: incorporation of radiolabeled polyprenyl chain and benzoquinone ring precursors. J. Eukaryote. Microbiol. 44, 60S.
25. 32 sterols in Pneumocystis carinii hominis-infected human lungs. J. Eukaryote. Microbiol. 43, 36S.
26. Ellis, J.E. (1994) Coenzyme Q homologs in parasitic protozoa as targets for chemotherapeutic attack. Parasitol. Today 10, 296-301.
27. Sun, I.L., Sun, E.E., Crane, F.L., Morré, D.J., Lindren, A. and Low, H. (1992) Requirement for coenzyme Q in plasma membrane electron transport. Proc. Natl. Acad. Sci. USA 80, 11126-11130.
28. Hughes, W.T., Gray, V.L., Gutteridge, W.E., Latter, V.S. and Pudney, M. (1990) Efficacy of a hydroxynaphthoquinone, 566C80, in experimental parasitic infections of AIDS pneumonitis. Antimicrob. Agents Chemother. 34, 225-228.
29. Ittarat, I., Asawamahasakda, W., Bartlett, M.S., Smith, J.W. and Meshnick, S.R. (1995) Effects of atovaquone and other inhibitors on Pneumocystis carinii dihydroorotate dehydrogenase. Antimicrob. Agents Chemother. 39, 325-328.
30. Gutteridge, W.E. (1991) Pneumocystis carinii: potential targets for chemotherapeutic attack. In: Biochemical Protozoology (Coombs, G.H. and North, M.J., Eds.), pp. 35-51. Taylor and Francis, London.
31. Polsen, D.C., Kovacs, J.A. and Lipschik, G.Y. (1994) Folate antagonists in the treatment of Pneumocystis carinii pneumonia. In: Pneumocystis carinii Pneumonia (Walzer, P.D., Ed.), 2nd edn., pp. 545-560. Marcel Dekker, New York.